timp 2 (Novus Biologicals)
Structured Review

Timp 2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/timp2+antibodies/pmc13033164-71-28-29?v=Novus+Biologicals
Average 94 stars, based on 1 article reviews
Images
1) Product Images from "Abnormal Trophoblast Invasion in Early-Onset Preeclampsia: The Involvement of Cystathionine β-Synthase, Specificity Protein 1 and microRNA-22"
Article Title: Abnormal Trophoblast Invasion in Early-Onset Preeclampsia: The Involvement of Cystathionine β-Synthase, Specificity Protein 1 and microRNA-22
Journal: Cureus
doi: 10.7759/cureus.104353
Figure Legend Snippet: mRNA expression of matrix metalloproteinases (MMPs) 2, 9 (a) and tissue inhibitors of metalloproteinase (TIMPs) 1, 2 (b) in the placental tissue samples from pregnancies complicated by early-onset preeclampsia (EOPE). Bar diagrams represent the relative mRNA expression of MMPs 2, 9 (a) and TIMPs 1,2 (b) in placentae from EOPE and normotensive, non-proteinuric controls. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a positive control. Data presented as mean ± SEM. Wilcoxon matched-pairs signed rank (MMPs 2, 9, TIMP-1) and paired t (TIMP-2) tests were applied, *p≤0.05 was considered statistically significant, *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001, ns: not significant.
Techniques Used: Expressing, Positive Control
Figure Legend Snippet: Protein expression of matrix metalloproteinases (MMPs) 2, 9, and their feedback inhibitor tissue inhibitors of metalloproteinase (TIMPs) 1, 2 as analysed by immunohistochemistry (IHC). Representative IHC images of placentae from early-onset preeclampsia (EOPE) (a, e, i, m) and normotensive, non-proteinuric controls (b, f, j, n) showing MMP-2, MMP-9, TIMP-1 and TIMP-2 localization in syncytiotrophoblasts, stromal component, and blood vessels. Positive controls for MMP-2 (human placenta (c)), MMP-9 (human spleen (g)), TIMP-1 (rat brain (k)) and TIMP-2 (human pancreas (o)). Negative controls for MMP-2 (d), MMP-9 (h), TIMP-1 (l) and TIMP-2 (p), Scale Bar: 50 µm.
Techniques Used: Expressing, Immunohistochemistry
Figure Legend Snippet: Protein expression of matrix metalloproteinases (MMPs) 2, 9 and tissue inhibitors of metalloproteinase (TIMPs) 1, 2 as analysed by immunofluorescence (IF) in EOPE and normotensive controls. Representative IF images of placentae from EOPE and normotensive, non-proteinuric controls showing MMP-2 (a, c (FITC stained), b, d (merged)], MMP-9 (e, g (FITC stained), f, h (merged)), TIMP-1 (i, k (TRITC stained), j, l (merged)) and TIMP-2 (m, o (FITC stained), n, p (merged)) localization in syncytiotrophoblasts, stromal component and blood vessels. Nuclei were stained by 4′,6-diamidino-2-phenylindole (DAPI); Scale Bar: 50 µm, FITC: Fluorescein isothiocyanate, TRITC: Tetramethylrhodamine isothiocyanate.
Techniques Used: Expressing, Immunofluorescence, Staining
Figure Legend Snippet: Immunoblot of matrix metalloproteinases (MMPs) 2, 9 (a, b) and tissue inhibitors of metalloproteinase (TIMPs) 1, 2 (c, d) in the placentae from early-onset preeclampsia (EOPE) as compared to normotensive, non-proteinuric control placentae. Representative images of immunoblot showing the protein expression of MMP-2 (a), MMP-9 (b), TIMP-1 (c) and TIMP-2 (d) in placental tissues of EOPE and normotensive, non-proteinuric controls. Bar diagrams represent the normalized values of MMPs 2, 9 (e) and TIMPs 1, 2 (f) with respect to β-actin (loading control). Data presented as mean ± SEM. Statistical analysis was done using the Wilcoxon matched-pairs signed rank (MMPs 2, 9, TIMP-1) and paired t (TIMP-2) tests; *p≤0.05 was considered statistically significant. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001, ns: not significant
Techniques Used: Western Blot, Control, Expressing
